Literature DB >> 7889854

Molecular dosimetry of 2,4-difluoroaniline in humans and rats by determination of hemoglobin adducts.

P J Boogaard1, G N Fokkema, G D Beulink, J Bouskill, N J van Sittert.   

Abstract

Exposure to 2,4-difluoroaniline (DFA) was monitored by GC-MS of DFA adducts bound to hemoglobin (Hb). In two studies, involving 20 and 16 workers potentially exposed to low concentrations of DFA, median concentrations of 10 (range 1-83) and 20 (range 4-322) pmole/g Hb were found, respectively. For better interpretation of these results, the in vivo binding of DFA to Hb was investigated. DFA was administered orally at doses of 0, 0.078, 0.775, 7.75, and 77.5 mumole/kg/day, to 10 male and 10 female Fischer 344 rats for 10 consecutive days (2 rats/sex/dose group). A linear relation between dose and adduct concentration was observed. At the two lowest doses (0.078 and 0.775 mumole/kg/day) no methemoglobinemia was observed, but adducts could easily be measured. At these doses, the mean adduct levels were in the same range as found in the human studies. As yet, no occupational exposure limit for DFA has been established. The German biological tolerance value (BAT-value) for aniline was set at 7.2 nmole/g Hb. This BAT-value is based on the relation between methemoglobinemia and adduct formation. The amount of Hb binding by aniline and DFA was found to be similar in the rat. Assuming that this is also the case in humans, the BAT-value for aniline may tentatively be used for DFA as well. In both studies of occupationally exposed workers, the adduct levels were well below this BAT-value.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889854      PMCID: PMC1566831          DOI: 10.1289/ehp.94102s627

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  8 in total

1.  Protein-carcinogen adducts in human dosimetry.

Authors:  P B Farmer; E Bailey
Journal:  Arch Toxicol Suppl       Date:  1989

2.  Biomonitoring of aromatic amines and alkylating agents by measuring hemoglobin adducts.

Authors:  H G Neumann
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

3.  Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.

Authors:  M S Bryant; P L Skipper; S R Tannenbaum; M Maclure
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

4.  Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring.

Authors:  J Lewalter; U Korallus
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

5.  Biomonitoring of arylamines: hemoglobin adducts of urea and carbamate pesticides.

Authors:  G Sabbioni; H G Neumann
Journal:  Carcinogenesis       Date:  1990-01       Impact factor: 4.944

6.  Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation.

Authors:  G Sabbioni
Journal:  Chem Biol Interact       Date:  1992-01       Impact factor: 5.192

7.  GC/MS analysis of biologically important aromatic amines. Application to human dosimetry.

Authors:  W G Stillwell; M S Bryant; J S Wishnok
Journal:  Biomed Environ Mass Spectrom       Date:  1987-05

8.  2,4-Difluoroaniline and 4-fluoroaniline exposure: monitoring by methaemoglobin and urine analyses.

Authors:  C V Eadsforth; C J Logan; B J Morrison; P A Warburton
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

  8 in total
  1 in total

Review 1.  Protein adduct biomarkers: state of the art.

Authors:  M J Meyer; W E Bechtold
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.